FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4230374143> ?p ?o ?g. }

• W4230374143 endingPage "1122" @default.
• W4230374143 startingPage "1115" @default.
• W4230374143 abstract "Background & aims Patients who have chronic intestinal failure require home parenteral nutrition (HPN) support. Intravenous lipid emulsions (IVLEs) are a vital part of HPN. The conventional IVLE is based on pure soybean oil, which contains a high concentration of omega-6 fatty acids. Alternative IVLEs are commercially available. These contain various oil blends and have different fatty acid compositions from soybean oil that could provide benefit to patients on HPN. The aim of this systematic review is to assess the effects of different IVLEs in adult patients requiring HPN. Methods A systematic literature search was conducted up to October 2019 using relevant search terms in the Medline, EMBASE and CINAHL databases. Only randomised controlled trials (RCTs) in adults on HPN that compared two or more IVLEs were included. Data were extracted and the Cochrane Collaboration's tool for assessing risk of bias was used. Results Six articles were identified for inclusion in this systematic review. Studies differed according to sample size, duration and the IVLEs compared. Four studies found no increased risk of adverse effects related to the different IVLEs, whilst one study found a higher frequency of serious adverse events with soybean oil. One study found higher serum α-tocopherol with the blend of soybean oil, medium chain triglycerides, olive oil and fish oil. Inflammatory markers were not affected by different IVLEs in three studies. Differences in liver function tests were minimal, but one study found slight abnormalities in patients receiving soybean oil. IVLEs containing olive oil or fish oil modified the blood fatty acid profile. No studies reported essential fatty acid deficiency. Conclusions There may be benefits of using alternative IVLEs to soybean oil-based emulsions in adults requiring HPN, although there is currently insufficient evidence to determine superiority of one formulation over another. More and larger RCTs are required in this area. Patients who have chronic intestinal failure require home parenteral nutrition (HPN) support. Intravenous lipid emulsions (IVLEs) are a vital part of HPN. The conventional IVLE is based on pure soybean oil, which contains a high concentration of omega-6 fatty acids. Alternative IVLEs are commercially available. These contain various oil blends and have different fatty acid compositions from soybean oil that could provide benefit to patients on HPN. The aim of this systematic review is to assess the effects of different IVLEs in adult patients requiring HPN. A systematic literature search was conducted up to October 2019 using relevant search terms in the Medline, EMBASE and CINAHL databases. Only randomised controlled trials (RCTs) in adults on HPN that compared two or more IVLEs were included. Data were extracted and the Cochrane Collaboration's tool for assessing risk of bias was used. Six articles were identified for inclusion in this systematic review. Studies differed according to sample size, duration and the IVLEs compared. Four studies found no increased risk of adverse effects related to the different IVLEs, whilst one study found a higher frequency of serious adverse events with soybean oil. One study found higher serum α-tocopherol with the blend of soybean oil, medium chain triglycerides, olive oil and fish oil. Inflammatory markers were not affected by different IVLEs in three studies. Differences in liver function tests were minimal, but one study found slight abnormalities in patients receiving soybean oil. IVLEs containing olive oil or fish oil modified the blood fatty acid profile. No studies reported essential fatty acid deficiency. There may be benefits of using alternative IVLEs to soybean oil-based emulsions in adults requiring HPN, although there is currently insufficient evidence to determine superiority of one formulation over another. More and larger RCTs are required in this area." @default.
• W4230374143 created "2022-05-11" @default.
• W4230374143 creator A5040484755 @default.
• W4230374143 creator A5074645101 @default.
• W4230374143 creator A5085018730 @default.
• W4230374143 date "2021-03-01" @default.
• W4230374143 modified "2023-09-25" @default.
• W4230374143 title "Influence of different intravenous lipid emulsions on fatty acid status and laboratory and clinical outcomes in adult patients receiving home parenteral nutrition: A systematic review" @default.
• W4230374143 cites W1986138319 @default.
• W4230374143 cites W2054014586 @default.
• W4230374143 cites W2073942915 @default.
• W4230374143 cites W2091078195 @default.
• W4230374143 cites W2094768453 @default.
• W4230374143 cites W2106156145 @default.
• W4230374143 cites W2114841940 @default.
• W4230374143 cites W2125778252 @default.
• W4230374143 cites W2127504862 @default.
• W4230374143 cites W2138378318 @default.
• W4230374143 cites W2143307989 @default.
• W4230374143 cites W2143659187 @default.
• W4230374143 cites W2144891204 @default.
• W4230374143 cites W2152716384 @default.
• W4230374143 cites W2180025784 @default.
• W4230374143 cites W2252662712 @default.
• W4230374143 cites W2563875151 @default.
• W4230374143 cites W2734083695 @default.
• W4230374143 cites W2789928518 @default.
• W4230374143 cites W2806072869 @default.
• W4230374143 cites W2902454812 @default.
• W4230374143 cites W4294215472 @default.
• W4230374143 doi "https://doi.org/10.1016/j.clnu.2020.07.014" @default.
• W4230374143 hasPublicationYear "2021" @default.
• W4230374143 type Work @default.
• W4230374143 citedByCount "7" @default.
• W4230374143 countsByYear W42303741432022 @default.
• W4230374143 countsByYear W42303741432023 @default.
• W4230374143 crossrefType "journal-article" @default.
• W4230374143 hasAuthorship W4230374143A5040484755 @default.
• W4230374143 hasAuthorship W4230374143A5074645101 @default.
• W4230374143 hasAuthorship W4230374143A5085018730 @default.
• W4230374143 hasBestOaLocation W42303741432 @default.
• W4230374143 hasConcept C118552586 @default.
• W4230374143 hasConcept C126322002 @default.
• W4230374143 hasConcept C142724271 @default.
• W4230374143 hasConcept C185592680 @default.
• W4230374143 hasConcept C197934379 @default.
• W4230374143 hasConcept C27415008 @default.
• W4230374143 hasConcept C2779885280 @default.
• W4230374143 hasConcept C2779946292 @default.
• W4230374143 hasConcept C2781145037 @default.
• W4230374143 hasConcept C2909208804 @default.
• W4230374143 hasConcept C2988377048 @default.
• W4230374143 hasConcept C31903555 @default.
• W4230374143 hasConcept C505870484 @default.
• W4230374143 hasConcept C535046627 @default.
• W4230374143 hasConcept C543025807 @default.
• W4230374143 hasConcept C55493867 @default.
• W4230374143 hasConcept C71924100 @default.
• W4230374143 hasConcept C78722104 @default.
• W4230374143 hasConcept C86803240 @default.
• W4230374143 hasConcept C95190672 @default.
• W4230374143 hasConceptScore W4230374143C118552586 @default.
• W4230374143 hasConceptScore W4230374143C126322002 @default.
• W4230374143 hasConceptScore W4230374143C142724271 @default.
• W4230374143 hasConceptScore W4230374143C185592680 @default.
• W4230374143 hasConceptScore W4230374143C197934379 @default.
• W4230374143 hasConceptScore W4230374143C27415008 @default.
• W4230374143 hasConceptScore W4230374143C2779885280 @default.
• W4230374143 hasConceptScore W4230374143C2779946292 @default.
• W4230374143 hasConceptScore W4230374143C2781145037 @default.
• W4230374143 hasConceptScore W4230374143C2909208804 @default.
• W4230374143 hasConceptScore W4230374143C2988377048 @default.
• W4230374143 hasConceptScore W4230374143C31903555 @default.
• W4230374143 hasConceptScore W4230374143C505870484 @default.
• W4230374143 hasConceptScore W4230374143C535046627 @default.
• W4230374143 hasConceptScore W4230374143C543025807 @default.
• W4230374143 hasConceptScore W4230374143C55493867 @default.
• W4230374143 hasConceptScore W4230374143C71924100 @default.
• W4230374143 hasConceptScore W4230374143C78722104 @default.
• W4230374143 hasConceptScore W4230374143C86803240 @default.
• W4230374143 hasConceptScore W4230374143C95190672 @default.
• W4230374143 hasIssue "3" @default.
• W4230374143 hasLocation W42303741431 @default.
• W4230374143 hasLocation W42303741432 @default.
• W4230374143 hasLocation W42303741433 @default.
• W4230374143 hasOpenAccess W4230374143 @default.
• W4230374143 hasPrimaryLocation W42303741431 @default.
• W4230374143 hasRelatedWork W2018415724 @default.
• W4230374143 hasRelatedWork W2059594256 @default.
• W4230374143 hasRelatedWork W2090790852 @default.
• W4230374143 hasRelatedWork W2136698015 @default.
• W4230374143 hasRelatedWork W2197789630 @default.
• W4230374143 hasRelatedWork W2375596232 @default.
• W4230374143 hasRelatedWork W2515655907 @default.
• W4230374143 hasRelatedWork W2563875151 @default.
• W4230374143 hasRelatedWork W4230374143 @default.
• W4230374143 hasRelatedWork W4282930467 @default.
• W4230374143 hasVolume "40" @default.

• next